Diffuse Large B-Cell Lymphoma, Lymphoma Follicular Clinical Trials

Diffuse Large B-Cell Lymphoma, Lymphoma Follicular

Explore clinical trials studying Diffuse Large B-Cell Lymphoma, Lymphoma Follicular. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Diffuse Large B-Cell Lymphoma, Lymphoma Follicular trial results

Completed

A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02596971

Conditions: Diffuse Large B-Cell Lymphoma, Lymphoma Follicular, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Rocky Mountain Cancer Center - Aurora Aurora, Colorado, United States

Georgetown University Medical Center Washington D.C., District of Columbia, United States

University Miami Miami, Florida, United States

New York Uni Medical Center New York, United States

View all 21 locations

View Trial Details

Related conditions